SCHEMBL23559235

SCHEMBL23559235

O=C(OCC(F)(F)C(=O)O)c1ccc(I)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 1/20 0.37
▸ GABRA1 P14867 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRA4 P48169 1/20 0.36
▸ GABRA6 Q16445 1/20 0.36
▸ CHRM2 P08172 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ HTR3A P46098 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23559287 0.86 GABRA1 (0.38) MAP2K1GABRA1GABRG2GABRB3GABRA5
SCHEMBL26312647 0.84 SERPINE1 (0.43) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559238 0.83 GABRA1 (0.39) MAP2K1GABRA1GABRG2GABRB3GABRA5
SCHEMBL23559357 0.82 CA12 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559309 0.82 GABRA1 (0.37) MAP2K1GABRA1GABRG2GABRB3GABRA5
SCHEMBL23559236 0.81 GABRA1 (0.39) MAP2K1GABRA1GABRG2GABRB3GABRA5
SCHEMBL26312645 0.79 AR (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559299 0.76 MAPK1 (0.47) TDP1KMT2ASLC6A3
SCHEMBL10641423 0.76 CYP4F2 (0.51) MAP2K1GABRA2CHRM2CHRM3MAOA
SCHEMBL23559363 0.75 ESR1 (0.38) KMT2ASLC6A3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230296981-A1 RESIST MATERIAL AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 — — US disclosed
US-20230296981-A1 RESIST MATERIAL AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 — — US disclosed
US-20230296980-A1 RESIST MATERIAL AND PATTERN FORMING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 — — US disclosed
US-20230296980-A1 RESIST MATERIAL AND PATTERN FORMING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 — — US disclosed
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SLC6A5, LIFR, SLC6A9 MAP2K1 666/4885GABRA1 2105/4885GABRG2 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback